RESTRUCTURING (Tables) |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and Related Activities [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Pre-Tax Restructuring Charges | A summary of the pre-tax restructuring charges is as follows:
(1) Cumulative charges incurred to date include $3.8 million in sales, general and administrative expense and $2.1 million in research and development expense.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Liabilities Related to Restructuring | A summary of the liabilities related to the 2025 restructuring is as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||